amiodarone has been researched along with Delayed Hypersensitivity in 3 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Excerpt | Relevance | Reference |
---|---|---|
"Amiodarone hydrochloride-induced thrombocytopenia seems to be an additional side effect in the course of amiodarone treatment." | 7.67 | Amiodarone-induced thrombocytopenia. ( Agmon, J; Ben-Sasson, E; Fuchs, J; Rotenberg, Z; Weinberger, I, 1987) |
"Amiodarone hydrochloride-induced thrombocytopenia seems to be an additional side effect in the course of amiodarone treatment." | 3.67 | Amiodarone-induced thrombocytopenia. ( Agmon, J; Ben-Sasson, E; Fuchs, J; Rotenberg, Z; Weinberger, I, 1987) |
"Amiodarone can cause pulmonary toxicity along with an increase in phospholipid in macrophages, lymphocytes, and other cell types." | 1.29 | Amiodarone causes decreased cell-mediated immune responses and inhibits the phospholipase C signaling pathway. ( Clarkson, CE; Lippmann, ML; Wilson, BD, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Fernando, SL | 1 |
Li, J | 1 |
Jain, A | 1 |
Weir, C | 1 |
Boyle, T | 1 |
Wilson, BD | 1 |
Clarkson, CE | 1 |
Lippmann, ML | 1 |
Weinberger, I | 1 |
Rotenberg, Z | 1 |
Fuchs, J | 1 |
Ben-Sasson, E | 1 |
Agmon, J | 1 |
3 other studies available for amiodarone and Delayed Hypersensitivity
Article | Year |
---|---|
Mixed drug reaction to amiodarone characterized by sequential immediate, immune complex, and delayed hypersensitivity.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Hypersensitivity; H | 2020 |
Amiodarone causes decreased cell-mediated immune responses and inhibits the phospholipase C signaling pathway.
Topics: Amiodarone; Animals; Dose-Response Relationship, Drug; Hypersensitivity, Delayed; Immune Tolerance; | 1993 |
Amiodarone-induced thrombocytopenia.
Topics: Aged; Amiodarone; Drug Hypersensitivity; Humans; Hypersensitivity, Delayed; Lymphocyte Activation; M | 1987 |